רווח נקי למניה ב-12 החודשים האחרונים meiragtx.com (MGTX)

The annual net income per share trend for MeiraGTx Holdings plc (MGTX) demonstrates capital dynamics, where 0.80 indicates the current level. However, the high cost of gene therapy development and the risk of liquidity shortages pose serious threats. The business maintains stability through its own cold-chain logistics hubs and strategic partnerships with pharma behemoths, which effectively protect operating margins from market pressure.
פילוחים אנליטיים של חברת MeiraGTx Corp (MGTX)

Net income per share over 12 months measures the actual efficiency of capital management by allocating the final financial result to a single common share to assess fundamental value. By analyzing the TTM earnings per share, an investor can identify a critical gap between the share price of MeiraGTx Holdings plc (MGTX) and the cash burn rate associated with costly gene therapy development, signaling bankruptcy risks.